SCHEMBL7154115

SCHEMBL7154115

CCOC(=O)CCN(N)S(=O)(=O)c1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.50
KMT2A Q03164 3/20 0.47
MAPK1 P28482 3/20 0.47
TDP1 Q9NUW8 2/20 0.47
ALDH1A1 P00352 2/20 0.47
L3MBTL1 Q9Y468 1/20 0.45
HSD11B1 P28845 1/20 0.45
ALOX5 P09917 1/20 0.44
LTA4H P09960 2/20 0.43
CYP4F2 P78329 1/20 0.42
CYP4A11 Q02928 1/20 0.42
S1PR4 O95977 1/20 0.41
LMNA P02545 1/20 0.41
TP53 P04637 1/20 0.41
HPGD P15428 1/20 0.41
S1PR1 P21453 1/20 0.41
STAT3 P40763 1/20 0.41
STAT1 P42224 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
HSD17B10 Q99714 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7980856 0.82 MAPK1 (0.40) KMT2AMAPK1TDP1HSD11B1MEN1
SCHEMBL9843107 0.82 SMN1; SMN2 (0.49) SMN1; SMN2KMT2AMAPK1TDP1ALDH1A1
SCHEMBL3864254 0.80 TBXA2R (0.45) KMT2AMAPK1TDP1ALDH1A1HSD11B1
SCHEMBL11511800 0.79 KMT2A (0.45) KMT2AMAPK1TDP1ALDH1A1L3MBTL1
SCHEMBL18837940 0.76 TDP1 (0.58) SMN1; SMN2KMT2ATDP1LMNAMEN1
SCHEMBL11482764 0.75 KMT2A (0.53) SMN1; SMN2KMT2AMAPK1ALDH1A1HSD11B1
SCHEMBL28244926 0.74 LMNA (0.65) SMN1; SMN2KMT2AMAPK1ALDH1A1L3MBTL1
SCHEMBL6999742 0.74 BMP1 (0.65) SMN1; SMN2KMT2AALDH1A1LMNATP53
SCHEMBL8657199 0.74 SMN1; SMN2 (0.52) SMN1; SMN2KMT2AALDH1A1L3MBTL1ALOX5
SCHEMBL3899542 0.74 KMT2A (0.47) SMN1; SMN2KMT2AMAPK1ALDH1A1HSD11B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030186967-A1 Acylresorcinol derivatives are selective vitronectin receptor inhibitors AMERICAN HOME PRODUCTS CORPORATION (US) 2003-10-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030186967-A1 Acylresorcinol derivatives are selective vitronectin receptor inhibitors ASGR1, TEK, APLNR SMN1; SMN2 3867/4885KMT2A 3514/4885MAPK1 540/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.